AzTrials
AzTrials

MONITORPETALNCT05853861

Promoting Early Intervention Timing and Attention to Language

A study testing JASPER Babble in people with MONITOR and COACH, run by University of California, Los Angeles at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The proposed study (PETAL: Promoting Early intervention Timing and Attention to Language) aims to determine the timing of intervention among infants with Increased Likelihood for Autism (ILA; at risk for autism by virtue of having an older sibling with autism) on communication and language outcomes at 24 months. Read more about this study

Who is it for?
Ages 6 to 8 months
Conditions the study is for
MONITOR, COACH
What is being tested?
JASPER Babble
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
2 sitesUnited States
Study dates
25 Nov 2024to 30 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 8 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • This study will recruit approximately 140 infants ages 6-8 months of age who are younger siblings of children with ASD.
  • Both males and females are eligible for study participation and will be recruited.
  • Family income is under the very low income described under the Department of Housing and Community DevelopmentDivision of Housing Policy Agreement for the city of Los Angeles.

Who cannot join

  • Infants who have seizures and are not stable on anti-seizure medication
  • Infant is expected to have surgery over the next year
  • Infant has associated physical disorders, and/or co-morbid with other syndromes or diseases.
  • All of the children will be free of additional sensory or motor impairments (e.g., Visual or hearing impairment) and othergenetic syndromes (e.g., Down Syndrome).
  • In addition, infants who are premature or less than 34 weeks (gestational age <34 weeks) will be excluded.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Connie Kasari, PhD contact

310-825-8342

kasari@gseis.ucla.edu

Consuelo Garcia, BS contact

562-301-6141

cogarcia@mednet.ucla.edu

United States2 sites, 2 recruiting
  • UCLA

    Los Angeles, California, 90095

    Connie Kasari, PhD

    Connie Kasari, PhD

    Recruiting
  • University of Massachusetts Medical Center

    Worcester, Massachusetts, 01655-0002

    Sarabeth Broder-Fingert, MD, sarabeth.broderfingert1@umassmed.edu

    Recruiting

Other trials in United States

About this study

The proposed study (PETAL: Promoting Early intervention Timing and Attention to Language) aims to determine the timing of intervention among infants with Increased Likelihood for Autism (ILA; at risk for autism by virtue of having an older sibling with autism) on communication and language outcomes at 24 months. Results of this study will determine when (9 vs 12 vs 15 months), and based on which measures (brain, language, or their combination) to augment parental support with a specialized parent-mediated coaching intervention for optimal outcomes on communication and language at 24 months.

Children will be recruited at 6-8 months of age and will begin with entry assessments. All children will first begin with the MONITOR condition (using Ages \& Stages Questionnaire (ASQ-3) and activity cards. Then when the child is 9 months, they will be randomized to continue with MONITOR condition or COACH condition (i.e. JASPER Babble) after second set of assessments. There are a total of 6 assessment timepoints (6-8 months of age, 9 months of age, 12 months of age, 15 months of age, 18 months of age, and 24 months of age). At time points of 9months and 12 months, the child will be randomized to COACH or MONITOR conditions. Once the child is randomized to COACH condition, they will continue with that condition until they terminate the study at 24 months. At the 15 months timepoint, there will no longer be a randomization. Children that were in the MONITOR condition will change to the COACH condition until they terminate the study.

Read the detailed description

A total of 140 infants aged 6-8 months old who are siblings of children with ASD will participate, with an expected 30-60infants recruited each year for 3 years. We expect to recruit a diverse sample of ILA infants and families in two sites, Los Angeles area and Boston area; many will be from traditionally marginalized and minoritized families, mostly low income. Referrals will be elicited from community partners with which both sites have a long history, including school systems, federally qualified health centers, local clinics, family resource centers, and family support groups.

This study will use a four phase, Sequential Multiple Assignment Randomized Trial (SMART) design to examine the effectiveness of transitioning to more intensive early intervention prior to 15 months of age, and to inform clinical decision-making concerning the optimal time to transition to more intensive intervention based on the specific characteristics of the child. Phase 1 begins at age 6 months; after baseline demographic, language, behavior and brain assessments, all children are offered the MONITOR intervention. Phase 2 begins at age 9 months; after language, behavior and brain assessments, all children are randomly assigned to transition to MONITOR plus COACH (with probability 1/3) versus continue with MONITOR (with probability 2/3). Phase 3 begins at age 12 months; following language, behavior, and brain assessments, children who have not yet transitioned to MONITOR plus COACH are randomly assigned (with equal probability) to transition to MONITOR plus COACH versus continue with MONITOR. Phase 4 begins at age 15 months; following language and behavior assessments, all remaining children will transition to MONITOR plus COACH.

The MONITOR condition consists will take a global, general domain approach to providing parents with information to track the early development of their infants, along with specific developmentally targeted activities. The well validated Ages and Stages-3+ screening tool along with activity cards will provide information to parents at each age. All parents will receive these materials at 3-month intervals, along with a developmentally chosen toy and book for their infant. We will provide an appropriate toy/book given we expect a diverse sample including many low resourced families. The questionnaire takes 10- 15 minutes to complete and covers developmental domains of communication, motor, problem-solving and personal-social, and is available in English, Spanish, and several other languages. We will drop off or mail the specific form and activity card (plus toy and book) to families at each of our specified ages---6, 9, 12, 15, 18, 21 and 24months. The intervention activities card includes suggestions for games and other fun events for parent- infant dyads. Moreover, each family will have access to the intervention team (text, call, zoom) on an as needed protocol, and we will keep track of all contact. The MONITOR intervention continues for all infants and parents throughout the study period even after receiving COACH intervention.

The COACH condition consists of JASPER Babble, which is an evidence-based intervention. Infant-parent dyads will be randomized to receive COACH (JASPER Babble) at 9, 12 or 15 months. JASPER Babble addresses early parent-child social communication by helping to close the 'feedback loop'. When parents talk and play with their infant, the infant increases their developmental behaviors which serve to provide more opportunities for parents to respond. JASPER Babble targets on babbling specifically will be incorporated into this feedback loop, and the importance of the blended intervention should be underscored, providing both context and targets. For infant-parentdyads randomized to COACH, we will set up once weekly remote (zoom) 1-hour coaching sessions in between assessment visits each 3 months. Similar to the ASQ-3+ monitoring intervention, parents will have access to the intervention team on as needed basis throughout the study if they request more input, and we will track this contact. Once randomized to COACH, parents will continue to receive the remotely delivered intervention throughout the study period.

Assessments will be administered at 6 timepoints. At entry (when child is 6-8 months), parents will sign consent, fill out demographic forms, treatment history form, Mullen, PCX, LENA, and EEG.

At the 9 months and 12 months timepoints, the Mullen, PCX, LENA, and EEG will be administered again.

At 15, 18, and 24 months, the Mullen, PCX, LENA will be administered. An ADOS-2 will also be administered at 24months only.

Conditions
MONITOR, COACH
Being tested
JASPER Babble
Keywords
autism, siblings, JASPER, speech, intervention
Medical subject headings
Autistic Disorder, Speech

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • JASPER BabbleBehavioural

    JASPER Babble is an evidence based early intervention that focuses on the core social communication and engagement skills of young children that are important to improvements in communication and language.

Study groups in NCT05853861
Study groupRoleWhat they receive
9 month coachingExperimentalParticipants receive JASPER Babble coaching at 9 months of age. Prior to 9 months, participants are just being monitored.
Receives: Behavioral: JASPER Babble
12 month coachingExperimentalParticipants receive JASPER Babble coaching at 12 months of age. Prior to 12 months, participants are just being monitored.
Receives: Behavioral: JASPER Babble
15 month coachingExperimentalParticipants receive JASPER Babble coaching at 15 months of age. Prior to 15 months, participants are just being monitored.
Receives: Behavioral: JASPER Babble

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mullen Early Learning Scales (MSEL)

    The MSEL provides expressive language scale T-scores. We will compare the changes in T-scores throughout the different time points, expecting improvement throughout each time point.

    Measured: child's 6,9,12,15,18 and 24 months of age

Secondary outcomes (3)
  1. Parent-Child Interaction (PCX)

    A 15-minute parent-child play-based interaction will be collected at every time point. Expressive language (canonical babble ratio, number of different consonants, vocalizations and number of words), communicative gestures, joint engagement, and object play will be measured and compared at each time point.

    Measured: child's 6,9,12,15,18 and 24 months of age

  2. LENA

    Parents will collect day-long naturalistic recordings of their child's language environment. We will compare them throughout each time point.

    Measured: child's 6,9,12,15,18 and 24 months of age

  3. Resting electroencephalogram test (EEG)

    EEG data (L Fronto-Temporal (alpha, gamma)- coherence) will be recorded in the participants' home. They will be compared at the distinct time frames they are collected.

    Measured: child's 6,9,12 months of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2023
  2. Study start25 Nov 2024
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05853861
Sponsor's protocol ID
22-001637
Acronym
PETAL
Status last verified
Mar 2026
First submitted
25 Apr 2023
Last updated
31 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing JASPER Babble in people with MONITOR and COACH, run by University of California, Los Angeles at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 31 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Connie Kasari, PhD (310-825-8342, kasari@gseis.ucla.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mullen Early Learning Scales (MSEL) (time frame: child's 6,9,12,15,18 and 24 months of age). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in